Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
23 Jan 2018 EMA Recommends Refusal of the Marketing Authorisation for Plitidepsin Haematologic malignancies - Anticancer agents & Biologic therapy
22 Jan 2018 NICE Develops a Medtech Innovation Briefing on the MammaTyper In Vitro Diagnostic Test Breast cancer - Pathology/Molecular biology - Personalised medicine
19 Jan 2018 NICE Issues Medtech Innovation Briefing on Plasma EGFR Mutation Tests for Adults with Locally Advanced or Metastatic NSCLC Lung and other thoracic tumours - Personalised medicine
18 Jan 2018 RET Driven Cancers Anticancer agents & Biologic therapy
17 Jan 2018 FDA Broadens Afatinib Indication to Previously Untreated, Metastatic NSCLC with Other Non-resistant EGFR Mutations Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
15 Jan 2018 FDA Approves Olaparib for Germline BRCA-Mutated Metastatic Breast Cancer Breast cancer - Personalised medicine - Anticancer agents & Biologic therapy
10 Jan 2018 FDA Approves Denosumab for the Prevention of Skeletal-Related Events in Patients with Multiple Myeloma Haematologic malignancies - Palliative and supportive care
11 Jan 2018 Chromosomal Instability in Cancer Translational research
09 Jan 2018 NICE Issues Medtech Innovation Briefing for NGS Panel for Solid Tumours in Children Cancer in Special Situations - Personalised medicine
05 Jan 2018 FDA Approves Hydroxyurea for Treatment of Paediatric Patients with Sickle Cell Anaemia Cancer in Special Situations - Anticancer agents & Biologic therapy
04 Jan 2018 FDA Issues Nilotinib Label Update Haematologic malignancies - Anticancer agents & Biologic therapy
03 Jan 2018 FDA Grants Regular Approval to Nivolumab for Adjuvant Treatment of Melanoma Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
02 Jan 2018 FDA Grants Accelerated Approval to Bosutinib Haematologic malignancies - Anticancer agents & Biologic therapy
02 Jan 2018 FDA Grants Regular Approval to Adjuvant Pertuzumab for HER2-positive Early Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
22 Dec 2017 FDA Grants Regular Approval to Cabozantinib Genitourinary cancers - Anticancer agents & Biologic therapy